Skip to main content

Table 2 Sample size, performance measures and diversity parameters for the nine molecular markers used to type the recurrent sample pairs used in this study

From: Molecular and epidemiological characterization of Plasmodium vivax recurrent infections in southern Mexico

Marker

N

GFR (%)

N a

% polyclonal

H E

 

(PI/RI)

(PI/RI)

(PI/RI)

(PI/RI)

(PI/RI)

msp3α

49/56

27.1/25.3

8/8

5.7/5.3

0.743/0.739

csp repeat

69/74

1.4/1.3

2/2

5.7/5.3

0.492/0.505

MS 40

62/69

0/0

5/5

0/0

0.616/0.59

MS 92

62/69

0/0

8/9

1.9/1.9

0.754/0.806

MS 116

61/68

1.6/1.4

12/11

0/0

0.822/0.744

MS 33

58/69

6.5/0

7/8

3.7/1.9

0.706/0.63

MS 176

49/63

21.0/8.8

6/6

0/0

0.692/0.747

MS 315

59/67

4.8/2.9

5/5

0/3.8

0.593/0.62

MS 206

50/57

19.4/17.4

10/10

0/0

0.825/0.831

  1. PI, primary infection; RI, recurrent infection.
  2. N, number of samples; GFR, genotype failure rate, Na, number of alleles,
  3. HE,effective heterozygosity.